Cite

HARVARD Citation

    Tayek, J. et al. (2022). A phase II, multicenter, open-label, randomized trial of pegfilgrastim for patients with alcohol-associated hepatitis. EClinicalMedicine. p. . [Online]. 
  
Back to record